Evaluation of Antihypoxic Activity of Kojic Acid in Mice
Scientific Journal of Kurdistan University of Medical Sciences · 2023
DOI: 10.61186/sjku.27.6.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Journal of Kurdistan University of Medical Sciences, 2023. Verfasst von Sepideh Yazdani und 3 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Aim: Hypoxia occurs especially in ischemia and heart attack, and finally can lead to death because of oxidative stress due to production of reactive oxygen species.Compounds with antioxidant activity can exhibit antihypoxic property.Kojic acid has good antioxidant activities.To the best of our knowledge, there have been no report about the protective effect of this compound against hypoxia-induced lethality in mice.Materials and Methods: Protective effects of kojic acid against hypoxia-induced lethality in 80 mice were evaluated by three experimental models of hypoxia including asphyctic, haemic and circulatory.Results: Antihypoxic activity of kojic acid was pronounced in asphyctic model and at the dose of 125 mg/kg, it prolonged the survival time in the negative control group (P
Zitieren
APA
Yazdani, S., Mohammadyan, M., Hosseinzadeh, M. H., & Ebrahimzadeh, M. A. (2023). Evaluation of Antihypoxic Activity of Kojic Acid in Mice. Scientific Journal of Kurdistan University of Medical Sciences. https://doi.org/10.61186/sjku.27.6.1
Vancouver
Yazdani S, Mohammadyan M, Hosseinzadeh MH, Ebrahimzadeh MA. Evaluation of Antihypoxic Activity of Kojic Acid in Mice. Scientific Journal of Kurdistan University of Medical Sciences. 2023. doi:10.61186/sjku.27.6.1
BibTeX
@article{Yazdani2023,
author = {Yazdani, Sepideh and Mohammadyan, Mahsa and Hosseinzadeh, Mohammad Hossein and Ebrahimzadeh, Mohammad Ali},
title = {Evaluation of Antihypoxic Activity of Kojic Acid in Mice},
journal = {Scientific Journal of Kurdistan University of Medical Sciences},
year = {2023},
doi = {10.61186/sjku.27.6.1}
}
EUVIMED